Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1134

1.

Clinicopathological and molecular features of responders to nivolumab for patients with advanced gastric cancer.

Mishima S, Kawazoe A, Nakamura Y, Sasaki A, Kotani D, Kuboki Y, Bando H, Kojima T, Doi T, Ohtsu A, Yoshino T, Kuwata T, Tsuji A, Shitara K.

J Immunother Cancer. 2019 Jan 31;7(1):24. doi: 10.1186/s40425-019-0514-3.

2.

Efficacy of metformin on postprandial plasma triglyceride concentration by administration timing in patients with type 2 diabetes mellitus: a randomized crossover pilot study.

Sato D, Morino K, Ogaku S, Tsuji A, Nishimura K, Sekine O, Ugi S, Maegawa H.

J Diabetes Investig. 2019 Jan 28. doi: 10.1111/jdi.13016. [Epub ahead of print]

3.

[Significance of monitoring cerebrospinal fluid leukocyte counts in managing central nervous system disease of acute myeloid leukemia in patients presenting with intracerebral hemorrhage upon initial examination].

Kawahara M, Teramoto Y, Asai A, Nagai S, Iwasa M, Fujishiro A, Nishimura R, Minamiguchi H, Tsuji A, Kito K, Andoh A.

Rinsho Ketsueki. 2018;59(12):2578-2582. doi: 10.11406/rinketsu.59.2578. Japanese.

PMID:
30626792
4.

Near-infrared photoimmunotherapy of pancreatic cancer using an indocyanine green-labeled anti-tissue factor antibody.

Aung W, Tsuji AB, Sugyo A, Takashima H, Yasunaga M, Matsumura Y, Higashi T.

World J Gastroenterol. 2018 Dec 28;24(48):5491-5504. doi: 10.3748/wjg.v24.i48.5491.

5.

Predictive equation to estimate post-mortem interval using spectrophotometric blood-colour values.

Usumoto Y, Kudo K, Tsuji A, Ihama Y, Ikeda N.

Med Sci Law. 2019 Jan 8:25802418819611. doi: 10.1177/0025802418819611. [Epub ahead of print]

PMID:
30621492
6.

Effects of quadriceps muscle neuromuscular electrical stimulation in living donor liver transplant recipients: phase-II single-blinded randomized controlled trial.

Hanada M, Soyama A, Hidaka M, Nagura H, Oikawa M, Tsuji A, Kasawara KT, Mathur S, Reid WD, Takatsuki M, Eguchi S, Kozu R.

Clin Rehabil. 2019 Jan 4:269215518821718. doi: 10.1177/0269215518821718. [Epub ahead of print]

PMID:
30607983
7.

A subanalysis of Japanese patients in a randomized, double-blind, placebo-controlled, phase 3 trial of nivolumab for patients with advanced gastric or gastro-esophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2).

Kato K, Satoh T, Muro K, Yoshikawa T, Tamura T, Hamamoto Y, Chin K, Minashi K, Tsuda M, Yamaguchi K, Machida N, Esaki T, Goto M, Komatsu Y, Nakajima TE, Sugimoto N, Yoshida K, Oki E, Nishina T, Tsuji A, Fujii H, Kunieda K, Saitoh S, Omuro Y, Azuma M, Iwamoto Y, Taku K, Fushida S, Chen LT, Kang YK, Boku N.

Gastric Cancer. 2018 Dec 1. doi: 10.1007/s10120-018-0899-6. [Epub ahead of print]

PMID:
30506519
8.

Inhibition of autophagy by chloroquine makes chemotherapy in nasopharyngeal carcinoma more efficient.

Aga T, Endo K, Tsuji A, Aga M, Moriyama-Kita M, Ueno T, Nakanishi Y, Hatano M, Kondo S, Sugimoto H, Wakisaka N, Yoshizaki T.

Auris Nasus Larynx. 2018 Dec 1. pii: S0385-8146(18)30588-1. doi: 10.1016/j.anl.2018.10.013. [Epub ahead of print]

PMID:
30514592
9.

Prolonged QRS duration as a predictor of right ventricular dysfunction after balloon pulmonary angioplasty.

Asano R, Ogo T, Ohta-Ogo K, Fukui S, Tsuji A, Ueda J, Konagai N, Fukuda T, Morita Y, Noguchi T, Kusano K, Anzai T, Ishibashi-Ueda H, Yasuda S.

Int J Cardiol. 2018 Nov 10. pii: S0167-5273(18)33068-7. doi: 10.1016/j.ijcard.2018.11.026. [Epub ahead of print]

PMID:
30448112
10.

aCGH Analysis of Predictive Biomarkers for Response to Bevacizumab plus Oxaliplatin- or Irinotecan-Based Chemotherapy in Patients with Metastatic Colorectal Cancer.

Fujita Y, Taguri M, Yamazaki K, Tsurutani J, Sakai K, Tsushima T, Nagase M, Tamagawa H, Ueda S, Tamura T, Tsuji Y, Murata K, Taira K, Denda T, Moriwaki T, Funai S, Nakajima TE, Muro K, Tsuji A, Yoshida M, Suyama K, Kurimoto T, Sugimoto N, Baba E, Seki N, Sato M, Shimura T, Boku N, Hyodo I, Yamanaka T, Nishio K.

Oncologist. 2018 Nov 13. pii: theoncologist.2018-0119. doi: 10.1634/theoncologist.2018-0119. [Epub ahead of print]

PMID:
30425180
11.
12.

Maintenance avelumab versus continuation of first-line chemotherapy in gastric cancer: JAVELIN Gastric 100 study design.

Moehler M, Ryu MH, Dvorkin M, Lee KW, Coşkun HŞ, Wong R, Chung HC, Poltoratsky A, Tsuji A, Yen CJ, Muntean AS, Le Sourd S, Vaccaro GM, Overton L, Boku N, Wainberg ZA, Patel M, Sharma M, Xiong H, Conti I, Taieb J, Bang YJ.

Future Oncol. 2019 Feb;15(6):567-577. doi: 10.2217/fon-2018-0668. Epub 2018 Oct 31.

13.

Direct comparison of 2‑amino[3‑11C]isobutyric acid and 2‑amino[11C]methyl‑isobutyric acid uptake in eight lung cancer xenograft models.

Sudo H, Tsuji AB, Sugyo A, Okada M, Kato K, Zhang MR, Saga T, Higashi T.

Int J Oncol. 2018 Dec;53(6):2737-2744. doi: 10.3892/ijo.2018.4596. Epub 2018 Oct 16.

PMID:
30334568
14.

A phase II study of NK012, a polymeric micelle formulation of SN-38, in unresectable, metastatic or recurrent colorectal cancer patients.

Hamaguchi T, Tsuji A, Yamaguchi K, Takeda K, Uetake H, Esaki T, Amagai K, Sakai D, Baba H, Kimura M, Matsumura Y, Tsukamoto T.

Cancer Chemother Pharmacol. 2018 Dec;82(6):1021-1029. doi: 10.1007/s00280-018-3693-6. Epub 2018 Oct 4.

15.

Tumor Sidedness and Enriched Gene Groups for Efficacy of First-line Cetuximab Treatment in Metastatic Colorectal Cancer.

Sunakawa Y, Mogushi K, Lenz HJ, Zhang W, Tsuji A, Takahashi T, Denda T, Shimada K, Kochi M, Nakamura M, Kotaka M, Segawa Y, Tanioka H, Negoro Y, Moran M, Astrow SH, Hsiang J, Stephens C, Fujii M, Ichikawa W.

Mol Cancer Ther. 2018 Dec;17(12):2788-2795. doi: 10.1158/1535-7163.MCT-18-0694. Epub 2018 Oct 1.

PMID:
30275242
16.

Efficacy Evaluation of Combination Treatment Using Gemcitabine and Radioimmunotherapy with 90Y-Labeled Fully Human Anti-CD147 Monoclonal Antibody 059-053 in a BxPC-3 Xenograft Mouse Model of Refractory Pancreatic Cancer.

Sugyo A, Tsuji AB, Sudo H, Koizumi M, Ukai Y, Kurosawa G, Kurosawa Y, Saga T, Higashi T.

Int J Mol Sci. 2018 Sep 29;19(10). pii: E2979. doi: 10.3390/ijms19102979.

17.

C-reactive Protein Level on Postoperative Day One is Associated with Chronic Postsurgical Pain After Mastectomy.

Hashimoto K, Tsuji A, Takenaka S, Ohmura A, Ueki R, Noma H, Imamura M, Miyoshi Y, Kariya N, Tatara T, Hirose M.

Anesth Pain Med. 2018 Aug 7;8(4):e79331. doi: 10.5812/aapm.79331. eCollection 2018 Aug.

18.

Immune-related Genes to Dominate Neutrophil-lymphocyte Ratio (NLR) Associated With Survival of Cetuximab Treatment in Metastatic Colorectal Cancer.

Sunakawa Y, Yang D, Cao S, Zhang W, Moran M, Astrow SH, Hsiang J, Stephens C, Tsuji A, Takahashi T, Tanioka H, Negoro Y, Takagane A, Tani S, Yamaguchi T, Eto T, Fujii M, Ichikawa W, Lenz HJ.

Clin Colorectal Cancer. 2018 Dec;17(4):e741-e749. doi: 10.1016/j.clcc.2018.08.002. Epub 2018 Aug 23.

PMID:
30219280
19.

Development of Pulmonary Arterial Hypertension in a Patient Treated with Qing-Dai (Chinese Herbal Medicine).

Misumi K, Ogo T, Ueda J, Tsuji A, Fukui S, Konagai N, Asano R, Yasuda S.

Intern Med. 2019 Feb 1;58(3):395-399. doi: 10.2169/internalmedicine.1523-18. Epub 2018 Sep 12.

20.

Radiation Dose Reduction at Pediatric CT: Use of Low Tube Voltage and Iterative Reconstruction.

Nagayama Y, Oda S, Nakaura T, Tsuji A, Urata J, Furusawa M, Utsunomiya D, Funama Y, Kidoh M, Yamashita Y.

Radiographics. 2018 Sep-Oct;38(5):1421-1440. doi: 10.1148/rg.2018180041. Review.

PMID:
30207943
21.

Evaluation of health-related quality of life via the Computer-Based Health Evaluation System (CHES) for Japanese metastatic breast cancer patients: a single-center pilot study.

Kikawa Y, Hatachi Y, Rumpold G, Tokiwa M, Takebe S, Ogata T, Satake H, Kato H, Tsuji A, Yasui H, Holzner B.

Breast Cancer. 2018 Sep 7. doi: 10.1007/s12282-018-0905-1. [Epub ahead of print]

PMID:
30194662
22.

Citrus peel polymethoxyflavones, sudachitin and nobiletin, induce distinct cellular responses in human keratinocyte HaCaT cells.

Abe S, Hirose S, Nishitani M, Yoshida I, Tsukayama M, Tsuji A, Yuasa K.

Biosci Biotechnol Biochem. 2018 Dec;82(12):2064-2071. doi: 10.1080/09168451.2018.1514246. Epub 2018 Sep 5.

PMID:
30185129
23.

Relationship Between Thymidine Kinase 1 Expression and Trifluridine/Tipiracil Therapy in Refractory Metastatic Colorectal Cancer: A Pooled Analysis of 2 Randomized Clinical Trials.

Yoshino T, Yamazaki K, Shinozaki E, Komatsu Y, Nishina T, Baba H, Tsuji A, Tsuji Y, Yamaguchi K, Sugimoto N, Denda T, Muro K, Takayama T, Esaki T, Hamamoto Y, Moriwaki T, Shimada Y, Goto M, Nakayama N, Fujii H, Tanase T, Ohtsu A.

Clin Colorectal Cancer. 2018 Dec;17(4):e719-e732. doi: 10.1016/j.clcc.2018.07.009. Epub 2018 Jul 26.

24.

Phase Ib study of irinotecan and ramucirumab for advanced gastric cancer previously treated with fluoropyrimidine with/without platinum and taxane.

Satake H, Sagawa T, Fujikawa K, Hatachi Y, Yasui H, Kotaka M, Kato T, Tsuji A.

Cancer Chemother Pharmacol. 2018 Nov;82(5):839-845. doi: 10.1007/s00280-018-3678-5. Epub 2018 Aug 30.

25.

By using either endogenous or transplanted stem cells, which could you prefer for neural regeneration?

Matsuda S, Nakagawa Y, Amano K, Ikeda Y, Tsuji A, Kitagishi Y.

Neural Regen Res. 2018 Oct;13(10):1731-1732. doi: 10.4103/1673-5374.238609. No abstract available.

26.

Aflibercept plus FOLFIRI in Asian patients with pretreated metastatic colorectal cancer: a randomized Phase III study.

Li J, Xu R, Qin S, Liu T, Pan H, Xu J, Bi F, Lim R, Zhang S, Ba Y, Bai Y, Fan N, Tsuji A, Yeh KH, Ma B, Wei V, Shi D, Magherini E, Shen L.

Future Oncol. 2018 Aug;14(20):2031-2044. doi: 10.2217/fon-2017-0669. Epub 2018 Aug 17. Erratum in: Future Oncol. 2019 Feb;15(4):451.

27.

Robust Domination of Lactobacillus sakei in Microbiota During Traditional Japanese Sake Starter Yamahai-Moto Fermentation and the Accompanying Changes in Metabolites.

Tsuji A, Kozawa M, Tokuda K, Enomoto T, Koyanagi T.

Curr Microbiol. 2018 Nov;75(11):1498-1505. doi: 10.1007/s00284-018-1551-8. Epub 2018 Aug 16.

PMID:
30116836
28.

Centrifugal Wave Front Propagation Speed for Localizing the Origin of Ventricular Arrhythmias: Investigation Using a New Ultra-High-Resolution Mapping System.

Masuda M, Asai M, Iida O, Okamoto S, Ishihara T, Nanto K, Kanda T, Tsujimura T, Matsuda Y, Okuno S, Ohashi T, Tsuji A, Mano T.

JACC Clin Electrophysiol. 2018 Mar;4(3):355-363. doi: 10.1016/j.jacep.2017.11.002. Epub 2017 Dec 20.

PMID:
30089561
29.

A prospective Phase II study to examine the relationship between quality of life and adverse events of first-line chemotherapy plus cetuximab in patients with KRAS wild-type unresectable metastatic colorectal cancer: QUACK trial.

Iwamoto S, Ooki A, Morita S, Hara H, Tanioka H, Satake H, Kataoka M, Kotaka M, Kagawa Y, Nakamura M, Shingai T, Ishikawa M, Miyake Y, Sudo T, Hashiguchi Y, Yabuno T, Sakamoto J, Tsuji A, Ando M, Yamaguchi K.

Cancer Med. 2018 Sep;7(9):4217-4227. doi: 10.1002/cam4.1623. Epub 2018 Jul 26.

30.

Beneficial Effect of Endovascular Treatment on Villalta Score in Japanese Patients With Chronic Iliofemoral Venous Thrombosis and Post-Thrombotic Syndrome.

Ueda J, Tsuji A, Ogo T, Asano R, Konagai N, Fukui S, Morita Y, Fukuda T, Yasuda S.

Circ J. 2018 Sep 25;82(10):2640-2646. doi: 10.1253/circj.CJ-17-1210. Epub 2018 Jul 21.

31.

Integrated treatment using intraperitoneal radioimmunotherapy and positron emission tomography-guided surgery with 64Cu-labeled cetuximab to treat early- and late-phase peritoneal dissemination in human gastrointestinal cancer xenografts.

Yoshii Y, Yoshimoto M, Matsumoto H, Tashima H, Iwao Y, Takuwa H, Yoshida E, Wakizaka H, Yamaya T, Zhang MR, Sugyo A, Hanadate S, Tsuji AB, Higashi T.

Oncotarget. 2018 Jun 22;9(48):28935-28950. doi: 10.18632/oncotarget.25649. eCollection 2018 Jun 22.

32.

Prevalence and risk factors of hepatitis B virus reactivation in patients with solid tumors with resolved HBV infection.

Kotake T, Satake H, Okita Y, Hatachi Y, Hamada M, Omiya M, Yasui H, Hashida T, Kaihara S, Inokuma T, Tsuji A.

Asia Pac J Clin Oncol. 2019 Feb;15(1):63-68. doi: 10.1111/ajco.13050. Epub 2018 Jul 8.

PMID:
29984542
33.

Predicting Poorly Differentiated Hepatocellular Carcinoma that Meets the Milan Criteria.

Koga Y, Beppu T, Miyata T, Kitano Y, Tsuji A, Nakagawa S, Arima K, Kuramoto K, Okabe H, Imai K, Hayashi H, Nitta H, Yamashita YI, Chikamoto A, Ishiko T, Baba H.

Anticancer Res. 2018 Jul;38(7):4093-4099. doi: 10.21873/anticanres.12699.

PMID:
29970535
34.

α-particle therapy for synovial sarcoma in the mouse using an astatine-211-labeled antibody against frizzled homolog 10.

Li HK, Sugyo A, Tsuji AB, Morokoshi Y, Minegishi K, Nagatsu K, Kanda H, Harada Y, Nagayama S, Katagiri T, Nakamura Y, Higashi T, Hasegawa S.

Cancer Sci. 2018 Jul;109(7):2302-2309. doi: 10.1111/cas.13636. Epub 2018 Jun 27.

35.

Early tumor shrinkage and depth of response in patients with advanced gastric cancer: a retrospective analysis of a randomized phase III study of first-line S-1 plus oxaliplatin vs. S-1 plus cisplatin.

Nishina T, Azuma M, Nishikawa K, Gotoh M, Bando H, Sugimoto N, Amagai K, Chin K, Niwa Y, Tsuji A, Imamura H, Tsuda M, Yasui H, Fujii H, Yamaguchi K, Yasui H, Hironaka S, Shimada K, Miwa H, Mitome T, Kageyama H, Hyodo I.

Gastric Cancer. 2019 Jan;22(1):138-146. doi: 10.1007/s10120-018-0845-7. Epub 2018 Jun 9.

PMID:
29948386
36.

Uniform intratumoral distribution of radioactivity produced using two different radioagents, 64Cu-cyclam-RAFT-c(-RGDfK-)4 and 64Cu-ATSM, improves therapeutic efficacy in a small animal tumor model.

Jin ZH, Tsuji AB, Degardin M, Sugyo A, Yoshii Y, Nagatsu K, Zhang MR, Fujibayashi Y, Dumy P, Boturyn D, Higashi T.

EJNMMI Res. 2018 Jun 19;8(1):54. doi: 10.1186/s13550-018-0407-3.

37.

Binding of Catechins to Staphylococcal Enterotoxin A.

Shimamura Y, Utsumi M, Hirai C, Nakano S, Ito S, Tsuji A, Ishii T, Hosoya T, Kan T, Ohashi N, Masuda S.

Molecules. 2018 May 9;23(5). pii: E1125. doi: 10.3390/molecules23051125.

38.

Isolation and characterization of peptides with dipeptidyl peptidase IV (DPPIV) inhibitory activity from natto using DPPIV from Aspergillus oryzae.

Sato K, Miyasaka S, Tsuji A, Tachi H.

Food Chem. 2018 Sep 30;261:51-56. doi: 10.1016/j.foodchem.2018.04.029. Epub 2018 Apr 11.

PMID:
29739605
39.

SLCO1B1 Polymorphism Is a Drug Response Predictive Marker for Advanced Pancreatic Cancer Patients Treated With Gemcitabine, S-1, or Gemcitabine Plus S-1.

Sato Y, Ueno H, Ioka T, Ohkawa S, Ikeda M, Shimamura T, Tsuji A, Tsuchiya Y, Furuse J, Ishii H, Furuya K, Iguchi H, Saito Y, Kaniwa N, Sawada JI, Sakamoto H, Sekine A, Okusaka T, Yoshida T; GEST.

Pancreas. 2018 May/Jun;47(5):637-642. doi: 10.1097/MPA.0000000000001052.

PMID:
29683977
40.

Implications of PI3K/AKT/PTEN Signaling on Superoxide Dismutases Expression and in the Pathogenesis of Alzheimer's Disease.

Matsuda S, Nakagawa Y, Tsuji A, Kitagishi Y, Nakanishi A, Murai T.

Diseases. 2018 Apr 20;6(2). pii: E28. doi: 10.3390/diseases6020028. Review.

41.

18F-fluorodeoxyglucose positron emission tomography to indicate conversion surgery in patients with initially unresectable locally advanced pancreatic cancer.

Okano K, Suto H, Oshima M, Ando Y, Nagao M, Kamada H, Kobara H, Masaki T, Okuyama H, Okita Y, Tsuji A, Suzuki Y.

Jpn J Clin Oncol. 2018 May 1;48(5):434-441. doi: 10.1093/jjco/hyy033.

PMID:
29590448
42.

A Multicenter Clinical Phase II Study of FOLFOXIRI Plus Bevacizumab as First-line Therapy in Patients With Metastatic Colorectal Cancer: QUATTRO Study.

Oki E, Kato T, Bando H, Yoshino T, Muro K, Taniguchi H, Kagawa Y, Yamazaki K, Yamaguchi T, Tsuji A, Iwamoto S, Nakayama G, Emi Y, Touyama T, Nakamura M, Kotaka M, Sakisaka H, Yamanaka T, Kanazawa A.

Clin Colorectal Cancer. 2018 Jun;17(2):147-155. doi: 10.1016/j.clcc.2018.01.011. Epub 2018 Feb 9.

43.

Prophylactic Effect of Dexamethasone on Regorafenib-Related Fatigue and/or Malaise: A Randomized, Placebo-Controlled, Double-Blind Clinical Study in Patients with Unresectable Metastatic Colorectal Cancer (KSCC1402/HGCSG1402).

Tanioka H, Miyamoto Y, Tsuji A, Asayama M, Shiraishi T, Yuki S, Kotaka M, Makiyama A, Shimokawa M, Shimose T, Masuda S, Yamaguchi T, Komatsu Y, Saeki H, Emi Y, Baba H, Oki E, Maehara Y; Kyushu Study Group of Clinical Cancer (KSCC).

Oncology. 2018;94(5):289-296. doi: 10.1159/000486624. Epub 2018 Mar 7.

PMID:
29514163
44.

Left atrial low-voltage areas predict atrial fibrillation recurrence after catheter ablation in patients with paroxysmal atrial fibrillation.

Masuda M, Fujita M, Iida O, Okamoto S, Ishihara T, Nanto K, Kanda T, Tsujimura T, Matsuda Y, Okuno S, Ohashi T, Tsuji A, Mano T.

Int J Cardiol. 2018 Apr 15;257:97-101. doi: 10.1016/j.ijcard.2017.12.089.

PMID:
29506746
45.

A phase II trial of capecitabine plus cisplatin (XP) for patients with advanced gastric cancer with early relapse after S-1 adjuvant therapy: XParTS-I trial.

Nishikawa K, Tsuburaya A, Yoshikawa T, Takahashi M, Tanabe K, Yamaguchi K, Yoshino S, Namikawa T, Aoyama T, Rino Y, Kawada J, Tsuji A, Taira K, Kimura Y, Kodera Y, Hirashima Y, Yabusaki H, Hirabayashi N, Fujitani K, Miyashita Y, Morita S, Sakamoto J.

Gastric Cancer. 2018 Sep;21(5):811-818. doi: 10.1007/s10120-018-0815-0. Epub 2018 Feb 27.

PMID:
29488122
46.

Application of 80-kVp scan and raw data-based iterative reconstruction for reduced iodine load abdominal-pelvic CT in patients at risk of contrast-induced nephropathy referred for oncological assessment: effects on radiation dose, image quality and renal function.

Nagayama Y, Tanoue S, Tsuji A, Urata J, Furusawa M, Oda S, Nakaura T, Utsunomiya D, Yoshida E, Yoshida M, Kidoh M, Tateishi M, Yamashita Y.

Br J Radiol. 2018 May;91(1085):20170632. doi: 10.1259/bjr.20170632. Epub 2018 Mar 2.

PMID:
29470108
47.

Phase I study of primary treatment with 5-FU, oxaliplatin, irinotecan, levofolinate, and panitumumab combination chemotherapy in patients with advanced/recurrent colorectal cancer involving the wild-type RAS gene: the JACCRO CC-14 study.

Satake H, Tsuji A, Nakamura M, Ogawa M, Kotake T, Hatachi Y, Yasui H, Takagane A, Okita Y, Nakamura K, Onikubo T, Takeuchi M, Fujii M.

Int J Clin Oncol. 2018 Jun;23(3):490-496. doi: 10.1007/s10147-017-1228-5. Epub 2018 Feb 20.

48.

Treatment using oxaliplatin and S-1 adjuvant chemotherapy for pathological stage III gastric cancer: a multicenter phase II study (TOSA trial) protocol.

Namikawa T, Maeda H, Kitagawa H, Oba K, Tsuji A, Yoshikawa T, Kobayashi M, Hanazaki K.

BMC Cancer. 2018 Feb 13;18(1):186. doi: 10.1186/s12885-018-4109-z.

49.

Perinatal factors affecting growth and development at age 3 years in extremely low birth weight infants born small for gestational age.

Matsuda N, Taki A, Tsuji A, Nakajima K, Takasawa K, Morioka C, Minosaki Y, Oku K, Kashimada K, Morio T.

Clin Pediatr Endocrinol. 2018;27(1):31-38. doi: 10.1297/cpe.27.31. Epub 2018 Jan 30.

50.

Wavelength division multiplexer based on cavity-resonator-integrated guided-mode resonance filters for a compact multi-wavelength light source.

Inoue J, Tsuji A, Kintaka K, Nishio K, Ura S.

Opt Express. 2018 Feb 5;26(3):2212-2219. doi: 10.1364/OE.26.002212.

PMID:
29401761

Supplemental Content

Support Center